Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00474695 · ClinicalTrials.gov registry record
Study Evaluating Genotypes Using Lucentis
A clinical trial, sponsored by University of Utah.
- Terminated
- Registry status
- 65
- Enrollment target
NCT00474695: Clinical Trial study, sponsored by University of Utah.
NCT00474695 is a clinical trial that was terminated before completion, run by University of Utah. The registered enrollment target is 65 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00474695 was terminated before completion, sponsored by University of Utah.
- TERMINATED
- Registry status
- 65 participants
- Enrollment target
Study Summary
The purpose of the study is to investigate whether the efficacy of Lucentis treatment for exudative age-related macular degeneration is associated with VEGF and HTRA1 DNA polymorphisms
Interventions
- DRUG Lucentis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2007-05 |
| Est. Completion | 2009-12 |
Why NCT00474695 stopped before completion
NCT00474695 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 65 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Lucentis is the first listed.
NCT00474695 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00474695 about?
NCT00474695 is a clinical study titled "Study Evaluating Genotypes Using Lucentis". The purpose of the study is to investigate whether the efficacy of Lucentis treatment for exudative age-related macular degeneration is associated with VEGF and HTRA1 DNA polymorphisms
What is the current status of trial NCT00474695?
This trial is currently terminated. The enrollment target is 65 participants. The study started on 2007-05. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00474695?
The interventions under investigation include: Lucentis (DRUG).
Who is sponsoring clinical trial NCT00474695?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03366116 · 65 participants · Phase 1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
- NCT03603730 · 65 participants · NA
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
- NCT03796559 · 65 participants · NA
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
- NCT03993106 · 65 participants · Phase 2
A Study of sEphB4-HSA in Kaposi Sarcoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia